Prognostic factors for progression of liver structural lesions in chronic hepatitis C patients (2008)
- Authors:
- USP affiliated authors: NITA, SUZANE KIOKO ONO - FM ; SILVA, LUIZ CAETANO DA - FM ; ALVES, VENANCIO AVANCINI FERREIRA - FM ; CARRILHO, FLAIR JOSÉ - FM
- Unidade: FM
- DOI: 10.3748/wjg.14.2522
- Subjects: HEPATITE C; HEPATITE CRÔNICA; EVOLUÇÃO CLÍNICA; INTERFERONS; PROGNÓSTICO
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: World journal of gastroenterology
- ISSN: 0003-4894
- Volume/Número/Paginação/Ano: v. 14, n. 16, p. 2522-2528, 2008
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: hybrid
- Licença: cc-by-nc
-
ABNT
MENDES, Liliana S. C et al. Prognostic factors for progression of liver structural lesions in chronic hepatitis C patients. World journal of gastroenterology, v. 14, n. 16, p. 2522-2528, 2008Tradução . . Disponível em: https://doi.org/10.3748/wjg.14.2522. Acesso em: 24 abr. 2024. -
APA
Mendes, L. S. C., Nita, M. E., Nita, S. K. O., Mello, E. S., Silva, L. C. da, Alves, V. A. F., & Carrilho, F. J. (2008). Prognostic factors for progression of liver structural lesions in chronic hepatitis C patients. World journal of gastroenterology, 14( 16), 2522-2528. doi:10.3748/wjg.14.2522 -
NLM
Mendes LSC, Nita ME, Nita SKO, Mello ES, Silva LC da, Alves VAF, Carrilho FJ. Prognostic factors for progression of liver structural lesions in chronic hepatitis C patients [Internet]. World journal of gastroenterology. 2008 ; 14( 16): 2522-2528.[citado 2024 abr. 24 ] Available from: https://doi.org/10.3748/wjg.14.2522 -
Vancouver
Mendes LSC, Nita ME, Nita SKO, Mello ES, Silva LC da, Alves VAF, Carrilho FJ. Prognostic factors for progression of liver structural lesions in chronic hepatitis C patients [Internet]. World journal of gastroenterology. 2008 ; 14( 16): 2522-2528.[citado 2024 abr. 24 ] Available from: https://doi.org/10.3748/wjg.14.2522 - High resistance to therapy in cirrhotic patients carrying HCV-RNA genotype 3
- High resistance to therapy in cirrhotic patients carrying HCV RNA genotype 3.
- Rapid and profound drop HCV RNA viremia induced by high dose of consensus IFN (CIFN) just before starting pegylated interferon (PEG-IFN) plus ribavirin (RBV) in chronic hepatitits C patients (pts) previously resistant to combined therapy (IFN+RBV): preliminary report
- Unpredictable outcome in lamivudine (LAM): resistant patients under high daily doses & early effects of combined therapy of lam plus pegylated interferon
- Tratamento da hepatite C
- Rapid and profound drop of HCV RNA viraemia induced by high dose of consensus interferon just before starting pegylated interferon plus ribavirin in chronic hepatitis C patients previously resistant to combined therapy:: preliminary report.
- A twelve-week period of follow-up after an end-of-treatment response in patients with chronic hepatitis C submitted to combined therapy is a reliable period to characterize a sustained response.
- A prospective study of the prevalence of hepatitis B and C virus co-infection among patients with chronic renal disease under hemodialysis
- Searching for chronic hepatitis B patients in a low prevalence area: role of racial origin
- A phylogenetic study of hepatitis B virus in chronically infected Brazilian patients of Western and Asian descent
Informações sobre o DOI: 10.3748/wjg.14.2522 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
